Pfizer Fined $106M in UK for Drug Pricing

Dec 08, 2016

Bloomberg

Pfizer Inc. and Flynn Pharma Ltd. were fined a record amount in the U.K. by charging unfair prices for unbranded versions of the Epanutin anti-epilepsy drug, according to a Bloomberg article.

The Competition and Markets Authority fined Pfizer 84.2 million pounds ($106 million) and Flynn Pharma 5.2 million pounds after they increased prices by as much as 2,600 percent in September 2012. The price increases occurred after Pfizer transferred distribution rights to Flynn, which sold the medicine by its generic name, phenytoin sodium, the story said.

Read the Bloomberg article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments